Ethics declarations Competing interests KGW and VJNB are co-founders and shareholders of Aprea Therapeutics AB, a company that develops novel p53-based cancer therapy
The break is essential for preventing receptor accommodation and consolidating tissue remodeling
An exploratory study on the association between serotonin and sleep breathing disorders
For Eli Lilly, total 2024 revenue was $45.04 billion, of which GLP-1 drugs generated $16.4 billion, representing 37% of total revenues
Reported or Plausible Symptoms Headache, flushing, dizziness, increased heart rate, fluid retention, swelling, joint discomfort, numbness or tingling, and injection reactions require clinical review